Skip to main content

Standardization of prothrombin fragment 1.2 measurement: effects of preanalytical variables and calibrator selection.

Hursting MJ, Slaughter TF, Stead AG, Szewczyk KM, Witt DJ, Greenberg CS

Publication: Arch Pathol Lab Med (1998) • Vol 122 • Page 31-6PMID: 9448013View on PubMed

Purpose

The purpose of this paper was to determine the effects of blood collection method, type of anticoagulant, and calibrator set on prothrombin fragment 1.2 (F1.2) measurements using three different commercially available ELISAs.

Conclusion

Interassay correlations in F1.2 measurements were highest when the same anticoagulant was used for each ELISA (Behring, OTC, or Baxter). Interassay and intraassay correlations between anticoagulant pairs were generally higher between the metal-ion chelators, citrate and the cocktail of EDTA, aprotinin, and D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone (PPACK), collectively referred to as EAP, than when one of the anticoagulants was heparin. Although only modest correlations were observed between the Behring and OTC ELISAs when specimens were collected by venipuncture and their respective recommended anticoagulants were used (citrate and heparin), collection of specimens through an arterial catheter led to very strong correlations between the Behring and OTC assay results when the recommended anticoagulants were used. When calibrators from one ELISA were used for calibration of a different ELISA, significant differences in F1.2 measurements were observed in all cases.

Studies (1)

Purpose

The purpose of this study was to determine the effects of blood collection method, type of anticoagulant, and calibrator set on F1.2 measurements using three different commercially available ELISAs. Blood was collected into either sodium citrate, lithium heparin, or a cocktail of including the anticoagulant EDTA, with aprotinin, and PPACK, referred to as EAP. Platelet-poor plasma was prepared within 1 hour, and specimens intended for comparison of the Baxter and OTC assays were stored at 2-8 degrees C for up to 4 hours before assay, while specimens intended for comparison of the Behring and OTC assays were stored at -70 degrees C for an unspecified amount of time, and specimens containing heparin or EAP were mixed with a solution containing heparin, EDTA, and citrate that adjusted specimen pH to 5.8-6.2 prior to frozen storage.

Summary of Findings

The Behring ELISA recommends the use of citrate and the OTC ELISA recommends use of heparin as anticoagulants. Correlations in plasma F1.2 measurements between these two assays, when the recommended anticoagulants were used, were modest for both normal specimens (r=0.49) and those from diseased patients (r=0.48). However, when the same anticoagulant was used for each assay, interassay correlations were higher (r=0.62, citrate; r=0.76, EAP; and r=0.88, heparin). The Baxter ELISA recommends the use of heparin, similar to the OTC ELISA. These two assays showed a very strong correlation when heparinated specimens were used (r=0.94). Interassay and intraassay correlations between anticoagulant pairs were generally higher for the metal-ion chelators, citrate and EAP, as opposed to comparisons with heparin. Collection of specimens through an arterial catheter, rather than by venipuncture, led to very strong correlations between the Behring and OTC assay results when the recommended anticoagulants were used (r=0.96), when citrate was used for both assays (r=0.96), or when heparin was used for both assays (r=0.97). When calibrators from one ELISA were used for a different ELISA, significant differences in F1.2 measurements were observed in all cases.

  • Biospecimens

    FluidPlasma
    FluidBlood
  • Preservation Types

    Frozen
  • Diagnoses

    Normal
    Coronary Artery Disease
    Not specified
    Other diagnoses
  • Platforms

    ProteinELISA
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionDiagnosis/ patient condition
    Sickle cell disease
    Surgical patient
    Thrombosis
    Trauma patient
    Biospecimen AcquisitionAnatomical location of blood draw
    Artery
    Vein
    Biospecimen AcquisitionAnticoagulant
    EDTA
    Lithium heparin
    PPACK
    Sodium citrate
    Biospecimen AcquisitionMethod of fluid acquisition
    Arterial catheter
    Venipuncture
    Analyte Extraction and PurificationProtease inhibitor
    Aprotinin
    No protease inhibitor added
    PPACKI
    ELISA SpecificReaction solution
    Baxter calibrators
    Behring calibrators
    OTC calibrators
    ELISA SpecificTechnology platform
    Baxter Prothrombin Fragment F1.2 ELISA
    Behring Enzygnost F1+2 ELISA
    OTC Thrombonostika F1.2 ELISA